NCT06239324View on ClinicalTrials.gov

Evaluation of Latanoprost Combined With Fractional Erbium- YAG Laser

PHASE1/PHASE2RecruitingINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

February 1, 2024

Primary Completion Date

April 20, 2024

Study Completion Date

May 1, 2024

Conditions
Alopecia Areata
Interventions
DRUG

Latanoprost

Comparing between Erbium YAG laser assisted drug delivery of latanoprost versus transepidermal latanoprost delivery by microneedling in alopecia areata treatment for all participants.

Trial Locations (1)

Unknown

RECRUITING

Qena Hospital, Qina

All Listed Sponsors
lead

Egymedicalpedia

INDUSTRY